Meningococcal B vaccine linked to lower gonorrhea risk
The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhea in young Territorians. The study, led by Adelaide University in partnership with NT Health, found that two doses of the 4CMenB vaccine were associated with a 38% lower risk of gonorrhea notifications in young people ages 14 to…
The 4CMenB vaccine, which protects against meningococcal B disease, may also reduce the risk of gonorrhea in young people, according to a new study. Researchers from Adelaide University and NT Health found that two doses of the vaccine were linked to a 38% lower risk of gonorrhea notifications among adolescents aged 14 to 22 in the Northern Territory.
The protective effect is likely due to the bacterial relations between meningococcal and gonorrhea infections. The study, published in Open Forum Infectious Diseases, adds to growing evidence that the MenB vaccine could provide modest protection against gonorrhea in addition to its established role in preventing invasive meningococcal B disease.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
